Skip to main content
MedicHelpLine
Join Free
Verified Professional Network190+ CountriesHIPAA-Aware Platform
Back to Drug Index
General MedicationsINJECTIONStandard

TOFIDENCE

TOCILIZUMAB-BAVI

Standard Dose
400MG/20ML
Max Dose
Refer to approved labeling
Primary Use
Review priority: STANDARD Marketing status: Prescription
Summary

Approval overview TOFIDENCE is listed in Drugs@FDA under application 761354 (BLA).

Review priority: STANDARD Marketing status: Prescription Active ingredient TOCILIZUMAB-BAVI Form and strength INJECTABLE;INJECTION - 400MG/20ML Sponsor BIOGEN MA Submission history Latest submission status date: 2025-03-06 00:00:00.

Structured Monograph

Clinical summary

Approval overview TOFIDENCE is listed in Drugs@FDA under application 761354 (BLA). Review priority: STANDARD Marketing status: Prescription Active ingredient TOCILIZUMAB-BAVI Form and strength INJECTABLE;INJECTION - 400MG/20ML Sponsor BIOGEN MA Submission history Latest submission status date: 2025-03-06 00:00:00. Submission type: SUPPL.

Monitoring

  • • Marketing status: Prescription
  • • Review priority: STANDARD

Interaction Notes

  • No interaction notes stored yet.